Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis

Overview of attention for article published in Biotechnology & Biotechnological Equipment, October 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 294 followers.

Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis https://t.co/35WR25oUu4 Save the date: https://t.co/GguFOjZALi #mpssymposium2024com #mps2024com more about mann

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.